Journal Review in Breast Surgery: Management of Hereditary Breast Cancer

Journal Review in Breast Surgery: Management ...

Up next

Clinical Challenges in Minimally Invasive Surgery: Emerging Robotics and Adapting Laparoscopy – An Interview with Dr. Jim Porter

Robotic surgery has moved from novelty to norm, and in this episode of Behind the Knife, Drs. James Jung and Joey Lew sit down with urologic pioneer and Medtronic CMO Dr. Jim Porter to dissect how we got here, what the data really say about “the death of laparoscopy,” and where c ...  Show more

Journal Review in Surgical Oncology: Melanoma

Join the Behind the Knife Surgical Oncology Team as we discuss the PRADO and NADINA randomized control trials regarding neoadjuvant therapy in Stage III melanoma with macroscopic nodal disease!Hosts:Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at th ...  Show more

Recommended Episodes

#278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscri ...

  Show more

7. Breast cancer
Surgery 101

In this episode, Dr Parveen Boora discusses breast cancer. Topics covered include: approach to the history and physical exam of breast masses indications for breast imaging and biopsy staging invasive cancer management of breast cancer surgery for primary tumors surgery for axill ...  Show more

Hereditary Breast Cancer, Genetic Testing, and Therapeutic Implications
Medscape InDiscussion: Triple-Negative Breast Cancer

Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991258). The topics and discussions ...  Show more

Germline Testing in Patients with Breast Cancer: ASCO-SSO Guideline
ASCO Guidelines

Dr. Isabelle Bedrosian and Dr. Mark Robson discuss the new guideline from ASCO and SSO on germline testing in patients with breast cancer. They discuss the framework for which patients should be offered BRCA1/2 testing, and what additional moderate- and high-penetrance genes may ...  Show more